Taiwan Advance Bio-Pharmaceutical Inc. carries a market capitalization of 904.50M, placing it among publicly traded companies globally.
| Market Cap | 904.50M |
| Enterprise Value | N/A |
Taiwan Advance Bio-Pharmaceutical Inc.'s stock has declined approximately -10.26786% over the past 52 weeks. The 50-day moving average sits at 10.36, while the 200-day moving average is 11.42.
| Beta (5Y) | N/A |
| 52-Week Price Change | -10.26786% |
| 50-Day Moving Average | 10.36 |
| 200-Day Moving Average | 11.42 |
| Average Volume (20 Days) | N/A |